Roundup Settlement Creates Financial Barriers for Those Who Want to Opt Out

A Missouri judge has given preliminary approval to a $7.25 billion settlement for cancer claims against Roundup weedkiller manufacturer Bayer. The agreement includes provisions that could financially penalize lawyers and plaintiffs who choose to reject the deal and pursue individual lawsuits instead.

A Missouri judge has granted preliminary approval to a massive $7.25 billion class action settlement aimed at resolving cancer claims against Roundup weedkiller, but the agreement contains several mechanisms designed to discourage plaintiffs from rejecting the deal.

The settlement structure includes financial penalties for attorneys whose clients opt out in large numbers, plus a provision allowing Bayer to reduce the total payout if too many people walk away from the agreement.

Under the terms, lawyers who represent more than 25 clients who reject the settlement will lose their eligibility for any legal fees from the case. Additionally, if more than 650 plaintiffs opt out, Bayer can subtract up to $400 million from the overall settlement fund.

Judge Timothy Boyer in St. Louis provided the preliminary approval on Wednesday for the deal covering thousands of current and potential future claims that allege the popular herbicide causes cancer.

Bayer, which owns Roundup manufacturer Monsanto, retains the authority to cancel the entire agreement if what it considers an “excessive” number of plaintiffs choose to opt out, though the company has not publicly defined that threshold.

Attorney Christopher Seeger, who participated in settlement negotiations, defended the fee restrictions. “The whole concept of class action (legal) fees is you’re providing a common benefit to everyone,” Seeger explained. When class members opt out, they’re “exposing the deal to risk – and that should be taken into account.”

The opt-out process itself has drawn criticism for its complexity. Plaintiffs must meet 11 separate requirements by June 4, including providing wet-ink signatures, government photo identification, and sworn statements.

Attorney Asim Badaruzzaman, who was not involved in the settlement negotiations, described the process as a “confusing maze” that “appears designed to trap cancer patients” in the settlement.

Bayer currently faces approximately 65,000 claims in state and federal courts alleging that Roundup exposure led to non-Hodgkin lymphoma. The company stated in a February 17 announcement that it agreed to the settlement “solely to contain the litigation.”

The pharmaceutical giant maintains that extensive research spanning decades demonstrates Roundup and its primary component glyphosate pose no danger to human health. While Bayer has won several recent court battles, plaintiffs have also secured significant victories, including a $2.1 billion Georgia jury award in 2025 and a $332 million California verdict in 2023.

Settlement amounts vary based on multiple criteria. According to plaintiffs’ attorneys, a younger individual with aggressive non-Hodgkin lymphoma who used Roundup professionally could expect approximately $165,000, while someone first diagnosed at age 78 or older would receive around $10,000.

The agreement requires plaintiffs’ lawyers to make their “best efforts” to recommend the settlement to clients while maintaining their “independent judgment” in providing legal advice.

One factor supporting acceptance of the settlement is an upcoming Supreme Court review that could significantly restrict future litigation. The high court will hear Bayer’s argument in April that federal regulations override state law claims regarding Roundup labeling requirements.

Seeger acknowledged that despite lawyers’ efforts to highlight the settlement’s benefits, some clients will inevitably say, “I want more, I want my day in court.” However, he expressed confidence that an “overwhelming” majority of plaintiffs will choose the guaranteed settlement payment over the uncertainty of individual litigation.

The final approval hearing is scheduled for July 9, when Judge Boyer will also review the legal fee application from settlement negotiators. The total amount designated for attorney compensation has not been disclosed in the public version of the agreement.